Correlates of Protection Against SIVmac251 Infection in Rhesus Macaques Immunized With Chimpanzee-Derived Adenovirus Vectors

[1]  T. Kepler,et al.  Pentavalent HIV-1 vaccine protects against simian-human immunodeficiency virus challenge , 2017, Nature Communications.

[2]  D. Barouch,et al.  Adenovirus serotype 5 vaccine vectors trigger IL-27–dependent inhibitory CD4+ T cell responses that impair CD8+ T cell function , 2016, Science Immunology.

[3]  H. Ertl,et al.  Antibody responses to prime–boost vaccination with an HIV-1 gp145 envelope protein and chimpanzee adenovirus vectors expressing HIV-1 gp140 , 2016, AIDS.

[4]  H. Herzel,et al.  Identification of Novel Nuclear Factor of Activated T Cell (NFAT)-associated Proteins in T Cells* , 2016, The Journal of Biological Chemistry.

[5]  C. Katlama,et al.  HIV-1-Specific Antibody Response and Function after DNA Prime and Recombinant Adenovirus 5 Boost HIV Vaccine in HIV-Infected Subjects , 2016, PloS one.

[6]  N. Câmara,et al.  Follicular helper T cell in immunity and autoimmunity , 2016, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[7]  M. Russo,et al.  HIF3α: the little we know , 2016, The FEBS journal.

[8]  S. Hammer,et al.  Effect of rAd5-Vector HIV-1 Preventive Vaccines on HIV-1 Acquisition: A Participant-Level Meta-Analysis of Randomized Trials , 2015, PloS one.

[9]  H. Schuitemaker,et al.  Protective efficacy of adenovirus/protein vaccines against SIV challenges in rhesus monkeys , 2015, Science.

[10]  D. Montefiori,et al.  Balance of cellular and humoral immunity determines the level of protection by HIV vaccines in rhesus macaque models of HIV infection , 2015, Proceedings of the National Academy of Sciences.

[11]  K. Fujio,et al.  Interleukin-27 in T Cell Immunity , 2015, International journal of molecular sciences.

[12]  Amit Kumar,et al.  TNF and TNF Receptor Superfamily Members in HIV infection: New Cellular Targets for Therapy? , 2013, Mediators of inflammation.

[13]  Ming O. Li,et al.  TGF-β: Guardian of T Cell Function , 2013, The Journal of Immunology.

[14]  N. Sardesai,et al.  DNA and virus particle vaccination protects against acquisition and confers control of viremia upon heterologous simian immunodeficiency virus challenge , 2013, Proceedings of the National Academy of Sciences.

[15]  L. Ferrucci,et al.  Distinct energy requirements for human memory CD4 T‐cell homeostatic functions , 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[16]  Jerome H. Kim,et al.  Antibodies with High Avidity to the gp120 Envelope Protein in Protection from Simian Immunodeficiency Virus SIVmac251 Acquisition in an Immunization Regimen That Mimics the RV-144 Thai Trial , 2012, Journal of Virology.

[17]  T. Greenough,et al.  A Novel Assay for Antibody-Dependent Cell-Mediated Cytotoxicity against HIV-1- or SIV-Infected Cells Reveals Incomplete Overlap with Antibodies Measured by Neutralization and Binding Assays , 2012, Journal of Virology.

[18]  A. Trkola,et al.  ADCC Develops Over Time during Persistent Infection with Live-Attenuated SIV and Is Associated with Complete Protection against SIVmac251 Challenge , 2012, PLoS pathogens.

[19]  M. Hudgens,et al.  SIVmac239 MVA vaccine with and without a DNA prime, similar prevention of infection by a repeated dose SIVsmE660 challenge despite different immune responses. , 2012, Vaccine.

[20]  Jerome H. Kim,et al.  Vaccine Protection Against Acquisition of Neutralization-Resistant SIV Challenges in Rhesus Monkeys , 2011, Nature.

[21]  W. Paul,et al.  An updated view on transcription factor GATA3-mediated regulation of Th1 and Th2 cell differentiation. , 2011, International immunology.

[22]  S. Crotty,et al.  ICOS receptor instructs T follicular helper cell versus effector cell differentiation via induction of the transcriptional repressor Bcl6. , 2011, Immunity.

[23]  M. Hudgens,et al.  Immune and Genetic Correlates of Vaccine Protection Against Mucosal Infection by SIV in Monkeys , 2011, Science Translational Medicine.

[24]  S. Hammer,et al.  Pre-Existing Adenovirus Immunity Modifies a Complex Mixed Th1 and Th2 Cytokine Response to an Ad5/HIV-1 Vaccine Candidate in Humans , 2011, PloS one.

[25]  Matthew S. Lewis,et al.  Profound early control of highly pathogenic SIV by an effector-memory T cell vaccine , 2011, Nature.

[26]  Z. Xiang,et al.  An efficient method of directly cloning chimpanzee adenovirus as a vaccine vector , 2010, Nature Protocols.

[27]  Mark G. Lewis,et al.  Response of a simian immunodeficiency virus (SIVmac251) to raltegravir: a basis for a new treatment for simian AIDS and an animal model for studying lentiviral persistence during antiretroviral therapy , 2010, Retrovirology.

[28]  Jerome H. Kim,et al.  Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. , 2009, The New England journal of medicine.

[29]  Burton E. Barnett,et al.  Bcl6 and Blimp-1 Are Reciprocal and Antagonistic Regulators of T Follicular Helper Cell Differentiation , 2009, Science.

[30]  A. Redig,et al.  Type I interferon (IFN)-dependent activation of Mnk1 and its role in the generation of growth inhibitory responses , 2009, Proceedings of the National Academy of Sciences.

[31]  Qiang Zhou,et al.  Treg versus Th17 lymphocyte lineages are cross-regulated by LIF versus IL-6 , 2009, Cell cycle.

[32]  Devan V Mehrotra,et al.  Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial , 2008, The Lancet.

[33]  Y. Mori,et al.  Regulatory role of neuron-restrictive silencing factor in expression of TRPC1. , 2006, Biochemical and biophysical research communications.

[34]  S. Ellenberg,et al.  Chimpanzee Adenovirus Antibodies in Humans, Sub-Saharan Africa , 2006, Emerging infectious diseases.

[35]  S. Staprans,et al.  bloodjournal.hematologylibrary.org at PENN STATE UNIVERSITY on March 1, 2013. For personal use , 2006 .

[36]  D. Watkins,et al.  Attenuation of Simian Immunodeficiency Virus SIVmac239 Infection by Prophylactic Immunization with DNA and Recombinant Adenoviral Vaccine Vectors Expressing Gag , 2005, Journal of Virology.

[37]  S. Hensley,et al.  Dendritic Cell Maturation, but Not CD8+ T Cell Induction, Is Dependent on Type I IFN Signaling during Vaccination with Adenovirus Vectors1 , 2005, The Journal of Immunology.

[38]  D. Montefiori,et al.  Replicating Rather than Nonreplicating Adenovirus-Human Immunodeficiency Virus Recombinant Vaccines Are Better at Eliciting Potent Cellular Immunity and Priming High-Titer Antibodies , 2005, Journal of Virology.

[39]  J. James.  First AIDS vaccine tested did not protect, but gives scientific leads. , 2003, AIDS treatment news.

[40]  P. Loetscher,et al.  Cxc Chemokine Receptor 5 Expression Defines Follicular Homing T Cells with B Cell Helper Function , 2000, The Journal of experimental medicine.